Gelston, E. A., Coller, J. K., Lopatko, O. V., James, H. M., Schmidt, H., White, J. M., & Somogyi, A. A. (2012). Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: A study using codeine in methadone‐ and buprenorphine‐maintained subjects. British journal of clinical pharmacology, 73(5), 786-794. https://doi.org/10.1111/j.1365-2125.2011.04145.x
Chicago Style (17th ed.) CitationGelston, Eloise A., Janet K. Coller, Olga V. Lopatko, Heather M. James, Helmut Schmidt, Jason M. White, and Andrew A. Somogyi. "Methadone Inhibits CYP2D6 and UGT2B7/2B4 in Vivo: A Study Using Codeine in Methadone‐ and Buprenorphine‐maintained Subjects." British Journal of Clinical Pharmacology 73, no. 5 (2012): 786-794. https://doi.org/10.1111/j.1365-2125.2011.04145.x.
MLA (9th ed.) CitationGelston, Eloise A., et al. "Methadone Inhibits CYP2D6 and UGT2B7/2B4 in Vivo: A Study Using Codeine in Methadone‐ and Buprenorphine‐maintained Subjects." British Journal of Clinical Pharmacology, vol. 73, no. 5, 2012, pp. 786-794, https://doi.org/10.1111/j.1365-2125.2011.04145.x.